Canada - English - Health Canada

genmed a division of pfizer canada ulc - mirtazapine - tablet (orally disintegrating) - 30mg - mirtazapine 30mg - miscellaneous antidepressants

Canada - English - Health Canada

genmed a division of pfizer canada ulc - mirtazapine - tablet (orally disintegrating) - 45mg - mirtazapine 45mg - miscellaneous antidepressants

United Kingdom - English - VMD (Veterinary Medicines Directorate)

piramal critical care limited - isoflurane - inhalation vapour, solution - neurological agent general anaesthetic - cats, dogs, horses, mouse, ornamental birds, rabbits, rat, reptiles

United States - English - NLM (National Library of Medicine)

alcon laboratories, inc. - betaxolol hydrochloride (unii: 6x97d2xt0o) (betaxolol - unii:o0zr1r6rz2) - kit - betoptic® pilo ophthalmic suspension is indicated for the reduction of elevated intraocular pressure in patients with primary open-angle glaucoma and ocular hypertension who are insufficiently responsive to betoptic® -s (failed to achieve target iop determined after multiple measurements over time). it is not known whether betoptic® pilo is equivalent in iop lowering efficacy to the administration of betoptic® -s 0.25% and pilocarpine 1.75% dosed separately. it is not known whether betoptic® pilo is equivalent to other beta-blockers given in combination with pilocarpine. betoptic® pilo ophthalmic suspension is contraindicated in patients with sinus bradycardia, greater than a first degree atrioventricular heart block, cardiogenic shock or patients with overt cardiac failure. betoptic® pilo ophthalmic suspension is also contraindicated in conditions where miosis is undesirable (e.g., peripheral anterior synechia, trauma, acute inflammatory disease of the anterior chamber, glaucoma occurring or persisting